InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-160.20%
↑ 11% vs avg
Percentile
P29
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
-180.57%
Historical baseline
PeriodValueYoY Change
2025-160.20%+9.5%
2024-176.92%+12.7%
2023-202.60%+84.0%
2022-1265.95%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-